Pharma channel feed

Form 483 cites Lupin man­u­fac­tur­ing site in In­dia for con­t­a­m­i­na­tion and oth­er qual­i­ty con­trol ob­ser­va­tions

3 years ago
R&D
FDA+

Vi­a­tris lands a court win over As­traZeneca, but gener­ics for block­buster in­haler still not ready to launch

3 years ago

Pfiz­er faces la­bor ac­tion in Aus­tralia as work­ers protest wage in­crease at man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Manufacturing

UK signs off on Sanofi, As­traZeneca's RSV an­ti­body four days af­ter Eu­rope

3 years ago

As­traZeneca dou­bles down on COPD aware­ness ef­forts dur­ing na­tion­al aware­ness month

3 years ago
Marketing

On­col­o­gists re­spond best to short, pre­cise and da­ta-rich mar­ket­ing mes­sages, study finds

3 years ago
Marketing

No­var­tis cuts 275 jobs at Illi­nois site to con­sol­i­date Zol­gens­ma man­u­fac­tur­ing in North Car­oli­na

3 years ago
People
Manufacturing

No­vavax tem­pers its rev­enue ex­pec­ta­tions as it un­veils PhI­II da­ta for bi­va­lent boost­er

3 years ago
R&D
Coronavirus

Catch­ing up with Keytru­da, Re­gen­eron scores front­line NSCLC ap­proval for Lib­tayo/chemo com­bo

3 years ago
FDA+

Bay­er CEO talks next steps on in­fla­tion, sup­ply chain sta­bil­i­ty amid Q3 growth

3 years ago

Twit­ter ad­ver­tis­ing pause or per­sist? Phar­mas qui­et­ly weigh op­tions in un­cer­tain time

3 years ago
Marketing

MRx roundup: J&J’s Janssen ‘Save Legs’ cam­paign de­tails first-year re­sults; AZ and Lil­ly both roll new tech tools

3 years ago
Marketing

FDA and PTO look to shore up in­con­sis­ten­cies around phar­ma patents

3 years ago
FDA+

SCO­TUS to re­view Am­gen-Sanofi patent bat­tle as a proxy for how nar­row­ly phar­ma patents will need to be writ­ten

3 years ago
Law

ONO ex­er­cis­es Fate CAR-T op­tion in lat­est twist to part­ner­s' four-year deal

3 years ago
Cell/Gene Tx

Astel­las sig­nals on­col­o­gy as­pi­ra­tions to health­care providers in ‘Change­mak­ers’ cam­paign

3 years ago
Marketing

Mer­ck con­tin­ues rare breast can­cer cam­paign fo­cused on chal­lenges for Black women

3 years ago
Marketing

In­smed, Al­ny­lam and oth­ers make Sci­ence's list of top 20 bio­phar­ma em­ploy­ers

3 years ago
Marketing

Te­va reach­es $523M agree­ment with New York in lat­est opi­oid-re­lat­ed set­tle­ment

3 years ago
Law

No­vo Nordisk plots com­mer­cial re­launch for We­govy as sup­plies are ex­pect­ed to re­turn

3 years ago
Marketing

Am­gen on IRA's drug price ne­go­ti­a­tions: 'Ma­te­r­i­al ad­verse ef­fec­t' on sales, busi­ness and op­er­a­tions

3 years ago

Sanofi, As­traZeneca clinch first OK for RSV an­ti­body — just as vac­cines line up at reg­u­la­tors

3 years ago
FDA+

Mer­ck con­fronts stig­ma and fear around lung can­cer screen­ing in ed­u­ca­tion­al cam­paign

3 years ago
Marketing

Re­gen­eron culls two drugs from pipeline amid dou­ble-dig­it rev­enue drop af­ter Covid mAb cock­tail pull

3 years ago
First page Previous page 162163164165166167168 Next page Last page
A service from the Financial Times